IRBESARTAN vs RAMIPRIL

Compare IRBESARTAN (Irbesartan) and RAMIPRIL (Ramipril) — clinical data, side effects, and patient experiences.

IRBESARTAN

Irbesartan, Avapro, Avalide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Irbesartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions. ( 1.1 ) Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes

an elevated serum creatinine

OralTablet

RAMIPRIL

Ramipril, Altace, Tritace · ACE Inhibitor

How it works

12.1 Mechanism of Action Ramipril and ramiprilat inhibit ACE in human subjects and animals. Angiotensin converting enzyme is a peptidyl dipeptidase that catalyzes the conversion of...

Approved for

See full prescribing information

OralTablet

Quick Comparison

IRBESARTANRAMIPRIL

Drug Class

ARB

ACE Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

IRBESARTAN

Nausea

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Drug Not Working

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Falls

1-10%

RAMIPRIL

Shortness of Breath

1-10%

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Vomiting

1-10%

Headache

1-10%

FDA Warnings

IRBESARTAN

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume or salt depletion prior to administration
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe heart failure, or volume depletion) may be at particular risk of developing acute renal failure or death on irbesartan tablets

RAMIPRIL

WARNINGS AND PRECAUTIONS ACE inhibitor use has been associated with the following: • Angioedema, with increased risk in patients with a prior history ( 5
3 ) • Increased risk of renal impairment when combined with another blocker of the renin-angiotensin-aldosterone system ( 5
, ACE inhibitors) affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving these drugs (including ramipril) may be subject to a variety of adverse reactions, some of them serious
Angioedema Head and Neck Angioedema: Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor

Clinical Trial Data

No head-to-head clinical studies found for IRBESARTAN vs RAMIPRIL.

IRBESARTAN vs RAMIPRIL: What You Should Know

Key Differences

IRBESARTAN is a ARB, while RAMIPRIL belongs to the ACE Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

IRBESARTAN carries 4 FDA warnings. RAMIPRIL carries 4 FDA warnings. Patients should discuss all warnings and contraindications with their healthcare provider before starting or switching medications..

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.

Related Comparisons

Lisinopril vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL→CAPTOPRIL AND HYDROCHLOROTHIAZIDE vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL TABLETS→CAPTOPRIL vs RAMIPRIL→RAMIPRIL vs TRANDOLAPRIL AND VERAPAMIL HYDROCHLORIDE→

Loading comparison data...

IRBESARTAN vs RAMIPRIL

Compare IRBESARTAN (Irbesartan) and RAMIPRIL (Ramipril) — clinical data, side effects, and patient experiences.

IRBESARTAN

Irbesartan, Avapro, Avalide · ARB

How it works

ARB agent

Approved for

1 INDICATIONS AND USAGE Irbesartan tablets are an angiotensin II receptor blocker (ARB) indicated for: Treatment of hypertension

to lower blood pressure. Lowering blood pressure reduces the risk of fatal and nonfatal cardiovascular events

primarily strokes and myocardial infarctions. ( 1.1 ) Treatment of diabetic nephropathy in hypertensive patients with type 2 diabetes

an elevated serum creatinine

OralTablet

RAMIPRIL

Ramipril, Altace, Tritace · ACE Inhibitor

How it works

12.1 Mechanism of Action Ramipril and ramiprilat inhibit ACE in human subjects and animals. Angiotensin converting enzyme is a peptidyl dipeptidase that catalyzes the conversion of...

Approved for

See full prescribing information

OralTablet

Quick Comparison

IRBESARTANRAMIPRIL

Drug Class

ARB

ACE Inhibitor

Route

Oral

Half-Life

—

FDA Approved

—

Pregnancy

—

Side Effect Frequency Comparison

Estimated frequency (%) based on clinical trial data

Side Effects

IRBESARTAN

Nausea

1-10%

Fatigue

1-10%

Diarrhea

1-10%

Drug Not Working

1-10%

Dizziness

1-10%

Shortness of Breath

1-10%

Headache

1-10%

Falls

1-10%

RAMIPRIL

Shortness of Breath

1-10%

Fatigue

1-10%

Nausea

1-10%

Diarrhea

1-10%

Dizziness

1-10%

Drug Not Working

1-10%

Vomiting

1-10%

Headache

1-10%

FDA Warnings

IRBESARTAN

5 WARNINGS AND PRECAUTIONS Hypotension: Correct volume or salt depletion prior to administration
Use of drugs that act on the renin-angiotensin system during the second and third trimesters of pregnancy reduces fetal renal function and increases fetal and neonatal morbidity and death
Potential neonatal adverse effects include skull hypoplasia, anuria, hypotension, renal failure, and death
, patients with renal artery stenosis, chronic kidney disease, severe heart failure, or volume depletion) may be at particular risk of developing acute renal failure or death on irbesartan tablets

RAMIPRIL

WARNINGS AND PRECAUTIONS ACE inhibitor use has been associated with the following: • Angioedema, with increased risk in patients with a prior history ( 5
3 ) • Increased risk of renal impairment when combined with another blocker of the renin-angiotensin-aldosterone system ( 5
, ACE inhibitors) affect the metabolism of eicosanoids and polypeptides, including endogenous bradykinin, patients receiving these drugs (including ramipril) may be subject to a variety of adverse reactions, some of them serious
Angioedema Head and Neck Angioedema: Patients with a history of angioedema unrelated to ACE inhibitor therapy may be at increased risk of angioedema while receiving an ACE inhibitor

Clinical Trial Data

No head-to-head clinical studies found for IRBESARTAN vs RAMIPRIL.

IRBESARTAN vs RAMIPRIL: What You Should Know

Key Differences

IRBESARTAN is a ARB, while RAMIPRIL belongs to the ACE Inhibitor class. This means they work through different pharmacological mechanisms, which may influence both efficacy and side effect profiles.

Safety Considerations

This comparison is for informational purposes only. Always consult a qualified healthcare professional before making medication decisions.